EYPT
EyePoint Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$13.30+1.99%
Price as of Jul 17, 2026
EYPT ownership
EyePoint Pharmaceuticals, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$109.7K
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
Jul
Context3-month price -12.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 14, 2026 | Duker Jay S.director, officer: President and CEO | Option | 16,667 | — |
| Jul 14, 2026 | Duker Jay S.director, officer: President and CEO | Tax | 8,059 | $14.72 |
| Jul 2, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Option | 2,437 | $8.26 |
| Jul 2, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Sell | 2,437 | $15.00 |
| Jul 2, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Option | 2,438 | $8.26 |
| Jul 2, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Sell | 2,438 | $15.02 |
| May 27, 2026 | Elston Georgeofficer: Chief Financial Officer | Option | 7,500 | — |
| May 27, 2026 | Elston Georgeofficer: Chief Financial Officer | Tax | 3,627 | $12.93 |
| Apr 20, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Sell | 2,437 | $15.00 |
| Apr 20, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Option | 2,437 | $8.26 |
| Mar 16, 2026 | Duker Jay S.director, officer: President and CEO | Buy | 1,500 | $13.15 |
| Mar 5, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Sell | 2,438 | $17.87 |
| Mar 5, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Option | 2,438 | $8.26 |
| Feb 18, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Sell | 2,437 | $15.00 |
| Feb 18, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Option | 2,437 | $8.26 |
| Jan 7, 2026 | Elston Georgeofficer: Chief Financial Officer | Option | 15,285 | — |
| Jan 7, 2026 | Duker Jay S.director, officer: President and CEO | Option | 20,793 | — |
| Jan 7, 2026 | Elston Georgeofficer: Chief Financial Officer | Tax | 4,487 | $16.86 |
| Jan 7, 2026 | Lurker Nancydirector | Option | 75,133 | — |
| Jan 7, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Option | 29,250 | $8.26 |
| Jan 7, 2026 | Ribeiro Ramiroofficer: Chief Medical Officer | Sell | 42,544 | $17.10 |
| Jan 7, 2026 | Duker Jay S.director, officer: President and CEO | Tax | 10,054 | $16.86 |
| Jan 6, 2026 | Landis John B.director | Grant | 40,000 | $17.48 |
| Jan 6, 2026 | Lurker Nancydirector | Option | 12,666 | — |
| Jan 6, 2026 | Duker Jay S.director, officer: President and CEO | Grant | 331,000 | $17.48 |
| Jan 6, 2026 | Sanders Reginald J.director | Grant | 40,000 | $17.48 |
| Jan 6, 2026 | Zaderej Karen L.director | Grant | 40,000 | $17.48 |
| Jan 6, 2026 | Lurker Nancydirector | Grant | 40,000 | $17.48 |
| Jan 6, 2026 | Duker Jay S.director, officer: President and CEO | Grant | 165,000 | — |
| Jan 6, 2026 | Duty Stuartdirector | Grant | 40,000 | $17.48 |
Source: EYPT SEC Form 4 filings, latest Jul 14, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their EYPT positions over the last 6 months (SEC Form 13F).
Increased
148
New positions
78
Reduced
84
Sold out
40
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 8.3M | May 15, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | Unchanged | 8.3M | May 15, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | Reduced | 8.3M | Feb 17, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 7.8M | Feb 17, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 7.2M | May 18, 2026 |
| BLACKROCK, INC. | Increased | 7.2M | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7.1M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 6.8M | Feb 12, 2026 |
| FEDERATED HERMES, INC. | Increased | 6.0M | Feb 12, 2026 |
| FEDERATED HERMES, INC. | Reduced | 5.7M | May 11, 2026 |
| FRANKLIN RESOURCES INC | Increased | 5.0M | May 13, 2026 |
| FRANKLIN RESOURCES INC | Increased | 5.0M | Feb 11, 2026 |
| VANGUARD GROUP INC | Increased | 4.8M | Jan 29, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 4.7M | Feb 17, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Increased | 3.7M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.